Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management, has been extensively studied in clinical trials
Calorie restriction with or without time-restricted eating in weight loss
The medical evaluation includes: Review of your health history, including current medications, medical conditions, allergies, and previous weight loss attempts Assessment of your eligibility for GLP-1 therapy based on BMI, health conditions, and contraindications Discussion of treatment options, expected outcomes, potential side effects, and risks Determination of the appropriate medication (semaglutide or tirzepatide), starting dose, and titration schedule A prescription written by a licensed healthcare provider (physician, nurse practitioner, or physician assistant) who has determined that GLP-1 therapy is medically appropriate for you This evaluation can occur in-person with your primary care provider or specialist, or via a telehealth platform like FormBlends
The biopsy can help determine whether the lesion is a benign oral melanotic macule or a malignant melanoma, a type of skin cancer
US$ 27.69
US$ 23.98
US$ 22.48
US$ 28.23
